These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 8011677

  • 1. Distribution of PAF-acetylhydrolase activity in human plasma low-density lipoprotein subfractions.
    Karabina SA, Liapikos TA, Grekas G, Goudevenos J, Tselepis AD.
    Biochim Biophys Acta; 1994 Jun 23; 1213(1):34-8. PubMed ID: 8011677
    [Abstract] [Full Text] [Related]

  • 2. Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemia.
    Karabina SA, Elisaf M, Bairaktari E, Tzallas C, Siamopoulos KC, Tselepis AD.
    Eur J Clin Invest; 1997 Jul 23; 27(7):595-602. PubMed ID: 9263748
    [Abstract] [Full Text] [Related]

  • 3. PAF-acetylhydrolase activity of Lp(a) before and during Cu(2+)-induced oxidative modification in vitro.
    Karabina SA, Elisaf MC, Goudevenos J, Siamopoulos KC, Sideris D, Tselepis AD.
    Atherosclerosis; 1996 Aug 23; 125(1):121-34. PubMed ID: 8831934
    [Abstract] [Full Text] [Related]

  • 4. Dissociable and nondissociable forms of platelet-activating factor acetylhydrolase in human plasma LDL: implications for LDL oxidative susceptibility.
    McCall MR, La Belle M, Forte TM, Krauss RM, Takanami Y, Tribble DL.
    Biochim Biophys Acta; 1999 Jan 29; 1437(1):23-36. PubMed ID: 9931415
    [Abstract] [Full Text] [Related]

  • 5. Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoprotein.
    Tsoukatos DC, Liapikos TA, Tselepis AD, Chapman MJ, Ninio E.
    Biochem J; 2001 Jul 15; 357(Pt 2):457-64. PubMed ID: 11439095
    [Abstract] [Full Text] [Related]

  • 6. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects.
    de Graaf J, Hak-Lemmers HL, Hectors MP, Demacker PN, Hendriks JC, Stalenhoef AF.
    Arterioscler Thromb; 1991 Jul 15; 11(2):298-306. PubMed ID: 1998647
    [Abstract] [Full Text] [Related]

  • 7. Identification of multiple dense LDL subfractions with enhanced susceptibility to in vitro oxidation among hypertriglyceridemic subjects. Normalization after clofibrate treatment.
    de Graaf J, Hendriks JC, Demacker PN, Stalenhoef AF.
    Arterioscler Thromb; 1993 May 15; 13(5):712-9. PubMed ID: 8485123
    [Abstract] [Full Text] [Related]

  • 8. Role of lecithin-cholesterol acyltransferase in the metabolism of oxidized phospholipids in plasma: studies with platelet-activating factor-acetyl hydrolase-deficient plasma.
    Subramanian VS, Goyal J, Miwa M, Sugatami J, Akiyama M, Liu M, Subbaiah PV.
    Biochim Biophys Acta; 1999 Jul 09; 1439(1):95-109. PubMed ID: 10395969
    [Abstract] [Full Text] [Related]

  • 9. Differences in the low density lipoprotein subfraction profile between oral contraceptive users and controls.
    de Graaf J, Swinkels DW, Demacker PN, de Haan AF, Stalenhoef AF.
    J Clin Endocrinol Metab; 1993 Jan 09; 76(1):197-202. PubMed ID: 8421088
    [Abstract] [Full Text] [Related]

  • 10. The low-density lipoprotein (LDL)-associated PAF-acetylhydrolase activity and the extent of LDL oxidation are important determinants of the autoantibody titers against oxidized LDL in patients with coronary artery disease.
    Lourida ES, Papathanasiou AI, Goudevenos JA, Tselepis AD.
    Prostaglandins Leukot Essent Fatty Acids; 2006 Aug 09; 75(2):117-26. PubMed ID: 16843649
    [Abstract] [Full Text] [Related]

  • 11. Differences in LDL receptor-mediated metabolism of three low density lipoprotein subfractions by human monocyte-derived macrophages: impact on the risk for atherosclerosis.
    de Graaf J, Hendriks JC, Swinkels DW, Demacker PN, Stalenhoef AF.
    Artery; 1993 Aug 09; 20(4):201-30. PubMed ID: 8250739
    [Abstract] [Full Text] [Related]

  • 12. Low density lipoprotein subfractions and [Ca2+]i in vascular smooth muscle cells.
    Weisser B, Locher R, de Graaf J, Vetter W.
    Circ Res; 1993 Jul 09; 73(1):118-24. PubMed ID: 8508523
    [Abstract] [Full Text] [Related]

  • 13. Hydrolysis of phosphatidylcholine during LDL oxidation is mediated by platelet-activating factor acetylhydrolase.
    Steinbrecher UP, Pritchard PH.
    J Lipid Res; 1989 Mar 09; 30(3):305-15. PubMed ID: 2723538
    [Abstract] [Full Text] [Related]

  • 14. Modulating effects of cholesterol feeding and simvastatin treatment on platelet-activating factor acetylhydrolase activity and lysophosphatidylcholine concentration.
    Zhang B, Fan P, Shimoji E, Itabe H, Miura S, Uehara Y, Matsunaga A, Saku K.
    Atherosclerosis; 2006 Jun 09; 186(2):291-301. PubMed ID: 16154574
    [Abstract] [Full Text] [Related]

  • 15. Novel function of lecithin-cholesterol acyltransferase. Hydrolysis of oxidized polar phospholipids generated during lipoprotein oxidation.
    Goyal J, Wang K, Liu M, Subbaiah PV.
    J Biol Chem; 1997 Jun 27; 272(26):16231-9. PubMed ID: 9195924
    [Abstract] [Full Text] [Related]

  • 16. Copper-catalyzed oxidation mediates PAF formation in human LDL subspecies. Protective role of PAF:acetylhydrolase in dense LDL.
    Tsoukatos DC, Arborati M, Liapikos T, Clay KL, Murphy RC, Chapman MJ, Ninio E.
    Arterioscler Thromb Vasc Biol; 1997 Dec 27; 17(12):3505-12. PubMed ID: 9437199
    [Abstract] [Full Text] [Related]

  • 17. Platelet-activating factor formation during oxidative modification of low-density lipoprotein when PAF-acetylhydrolase has been inactivated.
    Liapikos TA, Antonopoulou S, Karabina SP, Tsoukatos DC, Demopoulos CA, Tselepis AD.
    Biochim Biophys Acta; 1994 Jun 02; 1212(3):353-60. PubMed ID: 8199206
    [Abstract] [Full Text] [Related]

  • 18. Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIB.
    Tsimihodimos V, Karabina SA, Tambaki AP, Bairaktari E, Goudevenos JA, Chapman MJ, Elisaf M, Tselepis AD.
    Arterioscler Thromb Vasc Biol; 2002 Feb 01; 22(2):306-11. PubMed ID: 11834533
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.